Learn about our healthcare areas

Explore medicine and therapy products
Explore MedTech products

Find our latest news, stories and insights

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

Catch up on the latest press releases and download media assets here

Listening...

Search Results

No Results

    See all results

    Sorry, I don't understand. Please try again
    1. Home/
    2. News/
    3. Innovation/
    4. Innovation-opedia: What is a mosaic vaccine?
    Graphic featuring a syringe to illustrate an HIV vaccine trial
    Innovation

    Innovation-opedia: What is a mosaic vaccine?

    As the IAS Conference on HIV Science kicks off in Mexico City, we explain how an investigational HIV vaccine from the Janssen Pharmaceutical Companies of Johnson & Johnson works—and how researchers hope to help change lives around the world with it.

    Written by Johnson & Johnson
     | July 22, 2019
    July 22, 2019
    Illustrated handwritten definition of a mosaic HIV vaccine
    Illustration of a microscope with information about Janssen Vaccines & Prevention B.V. investigational HIV-1 vaccine regimen
    Inset- Innovation-opedia: What Is a Mosaic Vaccine?- mosaic-vaccine-4-immunizations_above
    Illustration of the # 4 explaining how many injections would be administered for Janssen’s investigational HIV-1 vaccine.
    Inset- Innovation-opedia: What Is a Mosaic Vaccine?- mosaic-vaccine-4-immunizations_below
    Illustration showing location of the IAS Conference on HIV Science with details about Janssen’s new Mosaico clinical trial.
    Illustrated quote by Janssen’s Maria Grazia Pau talking about the goal of creating a global HIV vaccine.

    We’re committed to helping lead the fight against HIV/AIDS

    Read about the many ways Johnson & Johnson is working to #makeHIVhistory.
    Learn more
    CTA-Red ribbon HIV

    HIV vaccine J&J Innovative Medicine Johnson & Johnson

    More from Johnson & Johnson

    Health & wellness
    October 29, 2025

    Juvenile myasthenia gravis: Inside one adolescent’s journey

    The condition is typically diagnosed in adults, but research suggests an uptick in adolescent patients. Learn more about the rare autoantibody disease, how one teen is managing it and why Johnson & Johnson is working to improve treatment options for patients of all ages.
    Read more
    Innovation
    October 28, 2025

    5 ways Johnson & Johnson is innovating in medicines and therapies

    From rare diseases to all-too-common cancers, Johnson & Johnson is on a mission to improve treatment options for people around the globe. Learn more about how the company is working to create new therapies for IBD, lung cancer, major depressive disorder, bladder cancer, myasthenia gravis and more.
    Read more
    Our company
    October 22, 2025

    Johnson & Johnson to collaborate with the New York Jets to promote better health in the community

    Teaming up to support healthcare in the local community and empower residents.
    Read more